Your session is about to expire
← Back to Search
ChatGPT for Educational Activities in Health Sciences Students (AIHSS Trial)
N/A
Waitlist Available
Led By Mirella Veras, PhD
Research Sponsored by Carleton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours
Awards & highlights
AIHSS Trial Summary
This trial compares an intervention (ChatGPT) to usual online resources to see which works better.
Who is the study for?
This trial is for health science students enrolled in the HLTH 3503 course, focusing on Chronic Health Conditions and Disability for Fall 2023. Participants must be able to give informed consent. Those who cannot provide this consent are excluded.Check my eligibility
What is being tested?
The study is testing the effectiveness of ChatGPT as an educational tool against usual online resources. It's a crossover randomized control trial where students are randomly placed into two groups: one using ChatGPT and another with standard materials.See study design
What are the potential side effects?
Since this trial involves educational tools rather than medical interventions, 'side effects' may include differences in learning outcomes or preferences rather than physical symptoms.
AIHSS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 24 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
System Usability Scale (SUS) scores are 0-100,The average SUS score is 68.
Secondary outcome measures
Student's perception of artificial intelligence, questionnaire reviwed by experts, No recognised gold standard measurement for outcome.
AIHSS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence (ChatGPT) GroupExperimental Treatment1 Intervention
Participants in Group A will be assigned to utilize ChatGPT as their tool to complete assignments. They will be given a period of six days to utilize artificial intelligence through ChatGPT for assignment completion. Along with the assignment instructions, participants will receive an ethical guideline and specific guidelines on how to effectively utilize ChatGPT. Once the intervention period is concluded, participants will be given a 24-hour window to complete a survey that assesses the usability of the technology. The survey aims to gather valuable feedback on the participants' experience and perception of using ChatGPT for their assignments. In addition, participants in Arm 1 will also be asked to fill out a survey regarding their perception of using artificial intelligence (AI) as an assistance tool to complete their assignments. This survey aims to gather insights into their thoughts, opinions, and attitudes towards utilizing AI in the learning process
Group II: Traditional Online tools GroupActive Control1 Intervention
Group B will serve as the control group in this study. Participants in this group will receive instructions on how to complete the assignment using traditional online tools available on the internet, without the use of artificial intelligence. They will have a timeframe of six days to complete the assignment using these conventional tools. Similar to participants in Arm 1, they will also be required to fill out a survey on technology usability, providing feedback on their experience with the online tools.
Find a Location
Who is running the clinical trial?
Carleton UniversityLead Sponsor
2 Previous Clinical Trials
142 Total Patients Enrolled
Université de MontréalOTHER
214 Previous Clinical Trials
102,745 Total Patients Enrolled
Mirella Veras, PhDPrincipal InvestigatorCarleton University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Traditional Online tools Group
- Group 2: Artificial Intelligence (ChatGPT) Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there available spots for participants in this trial?
"According to records on clinicaltrials.gov, the trial is no longer recruiting participants. It was originally posted as of September 1st 2023 and updated most recently on July 30th 2023. Despite this trial being closed for recruitment, there are 3 other medical studies currently enrolling patients at present time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger